ESMO Breast 2023 | Exploring novel strategies for breast cancer treatment

Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, Korea, outlines how researchers are looking beyond microtubule and topoisomerase inhibitors towards novel strategies for treating breast cancer. These include disrupting the tumor microenvironment and using antibody-drug conjugates in combination with PARP and immune-checkpoint inhibitors. This interview took place at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.